Medical Xpress

APRIL 20, 2023

An international team of 79 researchers have collaborated on a study published in Nature Medicine to delve into perivascular spaces (PVS), a poorly understood artifact seen in magnetic resonance imaging of cerebral small vessel disease, a leading cause of stroke and dementia.

Bioinformatics 75

Bioinformatics Genome Genomics Medicine 75

Scienmag

JUNE 28, 2021

McIndoe, bioinformatics expert and associate director of the Center for Biotechnology and Genomic Medicine at the Medical College of Georgia, is leading a dynamic, new $6.2 million federally funded initiative to support highly innovative research ideas in three areas with tremendous impact on health.

Bioinformatics 75

Bioinformatics Research Genome Genomics 75

Rethinking Clinical Trials

FEBRUARY 21, 2024

Hernandez is the executive director of the Duke Clinical Research Institute (DCRI) and professor of medicine and vice dean in the Duke University School of Medicine. ” The Grand Rounds session will be held on Friday, February 23, 2024, at 1:00 pm eastern. Join the online meeting.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Bioinformatics 130

Medical Xpress

NOVEMBER 16, 2022

HSE researchers have found genes characteristic of the most aggressive subtype of clear cell renal carcinoma.

Gene 81

Gene Bioinformatics Research 81

Rethinking Clinical Trials

FEBRUARY 19, 2024

Hernandez is the executive director of the Duke Clinical Research Institute (DCRI) and professor of medicine and vice dean in the Duke University School of Medicine. ” The Grand Rounds session will be held on Friday, February 23, 2024, at 1:00 pm eastern. Join the online meeting.

Trials 130

Trials Bioinformatics Clinical Trials Clinical Trials 130

Rethinking Clinical Trials

APRIL 26, 2023

Dr. Semler is an assistant professor of medicine and bioinformatics and the medical director of the Center for Learning Healthcare in the Vanderbilt Center for Clinical and Translational Research. .” The Grand Rounds session will be held on Friday, April 28, 2023, at 1:00 pm eastern. Join the online meeting.

Trials 130

Trials Bioinformatics Clinical Trials Clinical Trials 130

Pharmaceutical Technology

APRIL 5, 2023

Absci has collaborated with bioinformatics firm M2GEN to expedite the development of new cancer medicines. Absci stated that this collaboration combines AI drug creation technology and oncology bioinformatics, thereby reducing the time and cost of cancer drug development.

Development 130

Development Bioinformatics Drugs Immune Response 130

Medical Xpress

MAY 18, 2023

A team of bioinformatics researchers affiliated with multiple institutions in the U.S. The editors at Nature have also published a Research Briefing in the same journal issue outlining the work done by the team on this effort. Their study is reported in the journal Nature.

Genetics 98

Genetics Bioinformatics Research 98

Pharmaceutical Technology

FEBRUARY 17, 2023

Oncology-focused bioinformatics firm M2GEN has entered a multi-year strategic collaboration with Zephyr AI to identify treatments and cures for cancer patients. The collaboration will expedite the discovery of drugs and expand the use of investigations for cancer treatments.

Bioinformatics 147

Bioinformatics Production Clinical Trials Clinical Trials 147

Pharmaceutical Technology

JUNE 28, 2022

Researchers at the Rensselaer Polytechnic Institute in the US have received a five-year, $3.5m The latest research is part of the consortium of a new antiviral drug development centre named Center for Antiviral Medicines and Pandemic Preparedness (CAMPP), to be led by Scripps Research. Meanwhile, the NIH also granted a $2.7m

Development 147

Development Bioinformatics Drugs Allergies 147

pharmaphorum

JULY 20, 2022

Cancer Research UK has expanded an alliance with investment group Deep Science Ventures with a commitment to support the formation up to 10 new oncology startups. The post Cancer Research UK partnership aims to back 10 new startups appeared first on.

Research 84

Research Bioinformatics Gene Therapy Medicine 84

Scienmag

DECEMBER 28, 2021

Bioinformatics allows researchers to answer biological questions with advanced computational methods which involves the application of statistics and mathematical modeling. However, the concepts in structural bioinformatics and CADD […].

Bioinformatics 55

Bioinformatics Drugs Scientist Research 55

BioTech 365

AUGUST 14, 2020

EUR 129,00Angebotsende: Montag Sep-14-2020 16:12:38 CESTSofort-Kaufen für nur: EUR 129,00Sofort-Kaufen | Zur Liste der beobachteten Artikel hinzufügen Biotech365 : Eppendorf Research plus 100µl BioMarketplace You want to propose your products or a Biotech Company, a Biotech Tool or a Bioinformatic … Continue reading →

Bioinformatics 40

Bioinformatics Research Production 40

Drug Discovery World

MARCH 4, 2024

Clinical Microbiomics has acquired DNASense, a Danish microbiome clinical research organisation (CRO) specialised in long-read DNA and RNA sequencing technologies and bioinformatics. The acquisition adds long-read DNA and RNA sequencing technologies to Clinical Microbiomics’ multi-omics technologies for the microbiome field.

Bioinformatics 52

Bioinformatics RNA DNA Genome 52

Scienmag

FEBRUARY 4, 2021

Applications in Plant Sciences… SSRgenotyper is a newly developed, free bioinformatic tool that allows researchers to digitally genotype sequenced populations using simple sequence repeats (SSRs), a task that […].

Genotype 90

Genotype Bioinformatics Genome Genomics 90

BioTech 365

SEPTEMBER 9, 2020

$800.00 (0 Bids)End Date: Saturday Sep-12-2020 18:01:48 PDTBid now | Add to watch list Biotech365 : Eppendorf Research Plus Pipettes 4-pack BioMarketplace You want to propose your products or a Biotech Company, a Biotech Tool or a Bioinformatic software to … Continue reading →

Bioinformatics 40

Bioinformatics Research Production 40

Scienmag

APRIL 12, 2022

Researchers at The University of Texas MD Anderson Cancer Center have developed a new bioinformatics platform that predicts optimal treatment combinations for a given group of patients based on co-occurring tumor alterations. Abstract: LB119 Credit: MD Anderson Cancer Center Abstract: LB119 NEW ORLEANS ?

Bioinformatics 82

Bioinformatics Development Research 82

BioTech 365

DECEMBER 3, 2020

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Researchers develop a sequence analysis pipeline for virus discovery.Researchers from the University of Helsinki have developed a novel bioinformatics pipeline called Lazypipe for identifying viruses in host-associated … (..)

Bioinformatics 40

Bioinformatics Development Research 40

Scienmag

JANUARY 27, 2021

New research from the University of Illinois says yes. In a paper published in Evolutionary Bioinformatics, Illinois researchers show COVID-19 cases and mortality rates, among other […]. . – With cities around the globe locking down yet again amid soaring COVID-19 numbers, could seasonality be partially to blame?

Bioinformatics 95

Bioinformatics Research Genetics Medicine 95

pharmaphorum

JANUARY 19, 2022

Research into single-cell sequencing has been boosted with Single Cell Discoveries and BioTuring joining forces to refine the process. A rapidly growing field of research, single-cell RNA sequencing is vital for those working in areas such as oncology, immunology, and neuroscience.

RNA 72

RNA Research Life Science Bioinformatics 72

Medical Xpress

NOVEMBER 8, 2022

A team of researchers at Indiana University School of Medicine has developed specialized bioinformatics software designed to identify rare genetic variants in whole-genome sequencing studies. Zilin Li, Ph.D.,

Genetics 75

Genetics Bioinformatics Genome Genomics 75

pharmaphorum

SEPTEMBER 16, 2022

Alphabet subsidiary and precision health company Verily recently announced a breakthrough in its AI drug discovery GPCR research collaboration with Sosei Heptares. It is the horizon looker, seeing far more – and, at that, far more expediently – than the human researcher alone ever could.

Development 134

Development Research Drugs Clinical Trials 134

Drug Discovery World

JULY 5, 2023

AAV is optimal for gene therapy due to its efficiency and safety in humans; however, AAV processes can present obstacles for researchers. Join DDW for this exclusive free event , A Comprehensive Guide to Using Adeno-Associated Virus (AAV) Vectors in Gene Therapy, which is supported by Azenta Life Sciences.

Gene Therapy 52

Gene Therapy Gene Bioinformatics Life Science 52

Drug Discovery World

JUNE 29, 2023

AAV is optimal for gene therapy due to its efficiency and safety in humans; however, AAV processes can present obstacles for researchers. Join DDW for this exclusive free event , A Comprehensive Guide to Using Adeno-Associated Virus (AAV) Vectors in Gene Therapy, which is supported by Azenta Life Sciences.

Gene Therapy 52

Gene Therapy Gene Bioinformatics Life Science 52

Scienmag

FEBRUARY 8, 2021

Researchers at Uppsala University have tested the bioinformatic predictions made by another research group and have identified receptors that could be important players in the process. The molecular details of how SARS-CoV-2 enters cells and infects them are still not clear.

Bioinformatics 75

Bioinformatics Research Allergies Medicine 75

Drug Discovery World

JUNE 22, 2023

AAV is optimal for gene therapy due to its efficiency and safety in humans; however, AAV processes can present obstacles for researchers. Join DDW for this exclusive free event , A Comprehensive Guide to Using Adeno-Associated Virus (AAV) Vectors in Gene Therapy, which is supported by Azenta Life Sciences.

Gene Therapy 52

Gene Therapy Gene Bioinformatics Life Science 52

Drug Discovery World

FEBRUARY 17, 2023

The drug discovery sector is feeling the love this Valentine’s week, with several new research collaborations bringing together a range of expertise and advanced bioinformatics, automation and artificial intelligence technologies to speed up the development of new treatments.

Bioinformatics 52

Bioinformatics Drugs Genome Genomics 52

Drug Discovery World

OCTOBER 7, 2022

Researchers from King’s College London and The Institute of Cancer Research, London, have performed a deep dive into the different immune markers within tumour tissue and blood samples of early breast cancer patients whose cancer failed to respond to chemotherapy given to them prior to surgery.

Research 52

Research Immune Response Gene Bioinformatics 52

Scienmag

FEBRUARY 18, 2021

Study opens up new research avenues for understanding how viruses living in the gut affect human health Viruses are the most numerous biological entities on the planet.

Bioinformatics 70

Bioinformatics Scientist Research 70

Drug Discovery World

FEBRUARY 8, 2024

AAV is optimal for gene therapy due to its efficiency and safety in humans; however, AAV processes can present obstacles for researchers. These include automated solutions, proprietary genomics protocols, specialists to advise on global cGMP repository and logistics, plus experts to guide researchers through advanced therapy development.

Gene Therapy 59

Gene Therapy Gene Bioinformatics Life Science 59

Drug Discovery World

FEBRUARY 17, 2023

A new multi-year strategic partnership between M2GEN and Zephyr AI will leverage clinicogenomic data, bioinformatics, and artificial intelligence to accelerate drug discovery and expanded use cases for oncology treatments.

Bioinformatics 52

Bioinformatics Drugs Licensing Licensing 52

BioTech 365

AUGUST 31, 2020

Technology platform tool, PEARL-seq™, identifies binding sites in RNA by integrating proprietary bioinformatics workflow with chemical biology techniques for the rational design of rSM therapeutics WALTHAM, Mass.–(BUSINESS

RNA 52

RNA Bioinformatics Research 52

Drug Discovery World

APRIL 10, 2024

Located on the campus of the University of São Paulo (USP) in a 2,000-square-meter building, the newest member of the Pasteur Network has the capacity to house some 100 scientists working in 17 laboratories, four of which are Biosafety Level Three (BSL3) facilities, as well as a bioinformatics unit and several items of multiuser equipment.

Bioinformatics 52

Bioinformatics Research Scientist Drugs 52

Drug Discovery World

OCTOBER 18, 2022

Microbiome research company Clinical Microbiomics has acquired MS-Omics, a leading provider based in Denmark. ? . With this acquisition, Clinical Microbiomics hopes to further advance its systems biology platform and help researchers worldwide understand the microbiome and how to impact health and disease.? ? .

Bioinformatics 52

Bioinformatics Research Drugs 52

Drug Discovery World podcast

MARCH 25, 2022

The articles are called “The benefits of bioinformatics in genomics sequencing” and “LIMs vs ELNs – what does your lab need?”, In the first article, he talks to Lu Rahman and explains the important role of bioinformatics in genomics. . Researchers often ask whether a LIMS or an ELN is right for them.

Bioinformatics 52

Bioinformatics Genome Genomics Drugs 52

BioTech 365

JUNE 28, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Deep machine learning completes information about one million bioactive molecules.The Structural Bioinformatics and Network Biology laboratory, led by ICREA Researcher Dr. Patrick Aloy, has completed the bioactivity … Continue (..)

Bioinformatics 40

Bioinformatics Research 40

Drug Discovery World

JUNE 14, 2023

The study of health and disease through multi-omics research generates vast amounts of interconnected data. Unlocking their secrets requires complex bioinformatic exploration.

Bioinformatics 52

Bioinformatics Research Development Drugs 52